Sun Pharmaceutical Industries company profile
Company profile
Sun Pharmaceutical Industries has 47,000 employees and is headquartered in Mumbai, India.
Its tablets, capsules, injectables, inhalers and creams reach patients through a portfolio spanning neuropsychiatry, cardiology, diabetes, gastroenterology and oncology, among other areas. Alongside prescription medicines, the group sells over-the-counter vitamins, analgesics and digestive products, as well as antiretroviral drugs, peptides and steroids. It also supplies active pharmaceutical ingredients and generics for anti-cancer, immunosuppressant and controlled-substance medicines, with operations in India, the United States and other international markets.
In the fiscal year ended March 2026, Sun Pharmaceutical Industries Limited reported revenue of 584.6 billion rupees, up 11.2% from the previous year, and a net profit of 114.8 billion rupees. The company employs 47,000 people. Its headquarters are in Mumbai, India, and the company dates from 1983.
Company facts
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- India
- Headquarters
- Sun House, 400063, Mumbai
- Employees
- 47,000
- Chief executive
- Kirti Ganorkar
- Founded
- 1983
- Fiscal year
- April - March
- Listing
- SUNPHARMA · NSE
- Currency
- INR
- ISIN
- INE044A01036
- Website
- sunpharma.com
Sun Pharmaceutical Industries and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | India | $47.94B | 47,000 | 23.3% | 40.9 |
| Jiangsu Hengrui Pharmaceuticals600276 | China | $47.86B | 20,602 | 27.4% | 35.9 |
| Takeda Pharmaceutical4502 | Japan | $65.79B | 47,029 | 16.6% | 253.2 |
| Divi's LaboratoriesDIVISLAB | India | $31.67B | 11,565 | 34.0% | 88.0 |
| Hansoh Pharmaceutical Group3692 | Hong Kong SAR China | $25.82B | 9,643 | 37.3% | 27.6 |
| Torrent PharmaceuticalsTORNTPHARM | India | $19B | 18,258 | 22.2% | 78.9 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
